Monitoring Nonresponsive Patients Who Have Celiac Disease (DOI:10.1016/j.giec.2006.03.005);Monitoring Nonresponsive Patients Who Have Celiac Disease

Gastrointestinal Endoscopy Clinics of North America

Volumn 16, Issue 2, 2006, Pages 317-327

  Krauss, Norbert ^a   Schuppan, Detlef ^b  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CD103 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; DAPSONE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; PREDNISOLONE; PREDNISONE; STEROID; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR BETA CHAIN; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANTIGEN EXPRESSION; AUTOIMMUNE DISEASE; CANCER GROWTH; CANCER RISK; CAPSULE ENDOSCOPY; CELIAC DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; DERMATITIS HERPETIFORMIS; DIAGNOSTIC PROCEDURE; DIETITIAN; DISEASE ASSOCIATION; ENTEROPATHY; GENE REARRANGEMENT; GLUTEN FREE DIET; HISTOLOGY; HUMAN; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; INTESTINE BIOPSY; INTESTINE LYMPHOMA; JEJUNUM DISEASE; OSTEOPOROSIS; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SYMPTOMATOLOGY;

EID: 33646102668     PISSN: 10525157     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.giec.2006.07.001     Document Type: Erratum

References (33)

1. Farrell R.J., and Kelly C.P. Diagnosis of celiac sprue. Am J Gastroenterol 96 12 (2001) 3237-3246
2. Tommasini A., Not T., Kiren V., et al. Mass screening for coeliac disease using antihuman transglutaminase antibody assay. Arch Dis Child 89 (2004) 512-515
3. Bushara K.O. Neurologic presentation of celiac disease. Gastroenterology 128 (2005) S92-S97
4. Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology 119 (2000) 234-242
5. Koning F., Schuppan D., Cerf-Bensussan N., et al. Pathomechanisms in celiac disease. Ballieres Best Pract Res Clin Gastroenterol 19 3 (2005) 373-387
6. Murray J.A. Celiac disease in patients with an affected member, type 1 diabetes, iron-deficiency, or osteoporosis?. Gastroenterology 128 (2005) S52-S56
7. Dube C., Rostom A., Sy R., et al. The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology 128 (2005) S57-S67
8. Biagi F., and Corazza G.R. Defining gluten refractory enteropathy. Eur J Gastroenterol Hepatol 13 5 (2001) 561-565
9. Culliford A., Daly J., Diamond B., et al. The value of wireless capsule endoscopy in patients with complicated celiac disease. Gastrointest Endosc 62 1 (2005) 55-61
10. Hill I.D. What are the sensitivity and specificity of serologic tests for celiac disease? Do sensitivity and specificity vary in different populations?. Gastroenterology 128 (2005) S25-S32
11. Bardella M.T., Minolli G., Radaelli F., et al. Reevaluation of duodenal endoscopic markers in the diagnosis of celiac disease. Gastrointest Endosc 51 6 (2000) 714-716
12. American Gastroenterological Association. AGA medical position statement: celiac sprue. Gastroenterology 120 (2001) 1522-1525
13. Marsh M.N. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology 102 1 (1992) 330-354
14. American Gastroenterological Association. AGA technical review on celiac sprue. Gastroenterology 120 (2001) 1526-1540
15. Cellier C., Patey N., Mauvieux L., et al. Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology 114 (1998) 471-481
16. Apostolopoulos P., Alexandrakis G., Giannakoulopoulou E., et al. M2A wireless capsule endoscopy for diagnosing ulcerative jejunoileitis complicating celiac disease. Endoscopy 36 (2004) 247
17. Askling J., Linet M., Gridley G., et al. Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology 123 5 (2002) 1428-1435
18. Holmes G.K., Prior P., Lane M.R., et al. Malignancy in coeliac disease-effect of a gluten free diet. Gut 30 3 (1989) 333-338
19. Catassi C., Fabiani E., Corrao G., et al. Risk of non-Hodgkin lymphoma in celiac disease. JAMA 287 11 (2002) 1413-1419
20. Cellier C., Green P.H., Collin P., et al. International Conference on Capsule Endoscopy consensus for celiac disease. Endoscopy 7 10 (2005) 1055-1059
21. Petroniene R., Dubcenco E., Baker J.P., et al. Given capsule endoscopy in celiac disease: evaluation of diagnostic accuracy and interobserver agreement. Am J Gastroenterol 100 (2005) 685-694
22. Collin P. Should adults be screened for celiac disease? What are the benefits and harms of screening?. Gastroenterology 128 (2005) S104-S108
23. Chaudhary R., and Gosh S. Infliximab in refractory coeliac disease. Eur J Gastroenterol Hepatol 17 6 (2005) 603-604
24. Daum S., Cellier C., and Mulder C.J. Refractory coeliac disease. Ballieres Best Pract Res Clin Gastroenterol 19 3 (2005) 413-424
25. Abdulkarim A.S., Burgart L.J., See J., et al. Etiology of nonresponsive celiac disease: results of a systematic approach. Am J Gastroenterol 97 8 (2002) 2016-2021
26. Tursi A., Brandimarte G., and Giorgetti G. High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal. Am J Gastroenterol 98 4 (2003) 839-843
27. Wahab P.J., Meijer J.W., and Mulder C.J. Histologic follow-up of people with celiac disease on a gluten-free diet: slow and incomplete recovery. Am J Clin Pathol 118 3 (2002) 459-463
28. Turner S.M., Moorghen M., and Probert C.S. Refractory coeliac disease: remission with infliximab and immunomodulators. Eur J Gastroenterol Hepatol 17 6 (2005) 667-669
29. Olaussen R.W., Lovik A., Tollefsen S., et al. Effect of elemental diet on mucosal immunopathology and clinical symptoms in type 1 refractory celiac disease. Clin Gastroenterol Hepatol 3 9 (2005) 875-885
30. Mandal A., and Mayberry J. Elemental diet in the treatment of refractory coeliac disease. Eur J Gastroenterol Hepatol 13 1 (2001) 79-80
31. Gillett H.R., Arnott I.D., McIntyre M., et al. Successful infliximab treatment for steroid-refractory celiac disease: a case report. Gastroenterology 122 3 (2002) 800-805
32. Maurino E., Niveloni S., Chernavsky A., et al. Azathioprine in refractory sprue: results from a prospective, open-label study. Am J Gastroenterol 97 10 (2002) 2595-2602
33. Goerres M.S., Meijer J.W., Wahab P.J., et al. Azathioprine and prednisone combination therapy in refractory coeliac disease. Aliment Pharmacol Ther 18 5 (2003) 487-494